At-Home Ketamine Injections Offer a 'Blueprint' for Slew of New Anti-Depression Drugs

Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

At-Home Ketamine Injections Offer a 'Blueprint' for Slew of New Anti-Depression Drugs

Once known as a club drug, ketamine is now available as an at-home depression treatment.

With at least $1,500 and a psychiatric prescription, Angelenos can order a concierge at-home I.V. service through The I.V. Doc.

The company is partnering with Pasithea, a Florida-based biotech company focused on therapies for psychological and neurological disorders to deliver treatments for those whose anxiety, depression or PTSD is too crippling for them to leave the house.

Ketamine, which was developed as an anesthetic before gaining widespread infamy as a club drug, has become popular in recent years after a large body of research found it to be extremely effective in treating mental health disorders including depression and anxiety.

Because the drug needs to be administered with medical oversight, the practice will open the door for a new medical infrastructure. Instead of picking up prescription drugs from a pharmacy, patients can sit in a ketamine clinic for a few hours as the drug slowly seeps into their bloodstream via I.V. — or, in this case, order it for home consumption.

Pasithea psychiatrists prescribe patients ketamine "off-label," a term that describes when regulated drugs are prescribed for medical reasons other than their intended use.

A treatment program that costs $6,000 includes a psychiatric assessment to determine if the program is appropriate, six injections over the course of two to three weeks, and a follow up assessment to determine further counseling.

It's not the only one offering at-home care. Psychedelics-focused company Mindbloom facilitates ketamine tablet prescriptions sent to one's home. It provides users with someone to guide the patient through the journey.

Pasithea is trying to remake how drugs are delivered and administered.

"This is like a new field of psychiatry and neurology, what you call interventional psychiatry. It's basically psychiatrists giving drugs through different methods and routes of administration," Pasithea CEO Tiago Reis Marques said. "A big problem of this approach...particularly with drugs that need to be given by infusion, is a problem of access."

Drugs that don't exist as a pill are often extremely difficult to take because they often require a medical professional to inject them into a patient, rendering the pharmacy model useless for drugs like ketamine. But until recently, there has been little infrastructure to administer these therapies.

Clinics have popped up around Los Angeles to administer psychedelic drugs, including Ketamine Clinics Los Angeles, which was started in 2014 and administers intravenous ketamine injections.

There's also Field Trip Health, a psychedelics pharmaceutical company based in Canada. It opened a ketamine clinic in Santa Monica earlier this year that combines cognitive behavioral therapy with intramuscular ketamine injections.

"These kinds of therapy — psychedelic therapies, ketamine-assisted therapy — there's going to be a whole new clinical infrastructure that's built to deliver this, because the feeling you get when you walk into a place has a significant impact on the outcomes that people are going to have," said Field Trip Health co-founder Ronan Levy about his company's ketamine clinics.

Similarly, Pasithea has established a slew of "anti-depression clinics'' in the United Kingdom that prescribe intravenous ketamine injections to those who have depression. The company sees the ketamine clinics as a precursor to new forms of therapy that could one day involve psychedelics like psilocybin (colloquially known as magic mushrooms) and MDMA.

"We can leverage and we can use the infrastructure we've built to reintroduce any type of treatment that cannot be given in a typical pill form and needs to be given through these new methods and new routes of administration," Marques, who is also a psychiatrist, said.

Despite the many innovations that have come out of ketamine therapy, they rarely reach the people who often experience a lot of depression, anxiety and PTSD: the poor. Very few insurance companies foot the bill for ketamine treatments (which can cost upwards of $1,000) because ketamine has to be prescribed for off-label.

"It's out of pocket, it's not for everyone, unfortunately," Marques said. "But we hope to expand our reach and be able to provide the other types of treatments."

Correction: An earlier version incorrectly stated Mindbloom provides ketamine to patients and that it is based in Seattle. The company is remote and only facilitates prescriptions sent by third-parties.

Subscribe to our newsletter to catch every headline.


Genies Wants To Help Creators Build ‘Avatar Ecosystems’

Christian Hetrick

Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.

Genies Wants To Help Creators Build ‘Avatar Ecosystems’

When avatar startup Genies raised $150 million in April, the company released an unusual message to the public: “Farewell.”

The Marina del Rey-based unicorn, which makes cartoon-like avatars for celebrities and aims to “build an avatar for every single person on Earth,” didn’t go under. Rather, Genies announced it would stay quiet for a while to focus on building avatar-creation products.

Genies representatives told dot.LA that the firm is now seeking more creators to try its creation tools for 3D avatars, digital fashion items and virtual experiences. On Thursday, the startup launched a three-week program called DIY Collective, which will mentor and financially support up-and-coming creatives.

Read moreShow less

Here's What To Expect At LA Tech Week

Christian Hetrick

Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.

Here's What To Expect At LA Tech Week

LA Tech Week—a weeklong showcase of the region’s growing startup ecosystem—is coming this August.

The seven-day series of events, from Aug. 15 through Aug. 21, is a chance for the Los Angeles startup community to network, share insights and pitch themselves to investors. It comes a year after hundreds of people gathered for a similar event that allowed the L.A. tech community—often in the shadow of Silicon Valley—to flex its muscles.

From fireside chats with prominent founders to a panel on aerospace, here are some highlights from the roughly 30 events happening during LA Tech Week, including one hosted by dot.LA.

Read moreShow less

Motional Links With Uber to Make Robotaxis a Reality

Samson Amore

Samson Amore is a reporter for dot.LA. He holds a degree in journalism from Emerson College and previously covered technology and entertainment for TheWrap and reported on the SoCal startup scene for the Los Angeles Business Journal. Send tips or pitches to and find him on Twitter @Samsonamore.

Image courtesy of Motional

Motional, a self-driving taxi startup backed by Hyundai, will partner with Uber to bring its robotic taxis to cities throughout the United States within the next decade as part of its push to get people more comfortable with the concept of taking a ride in a driverless electric vehicle.

Read moreShow less